Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Leisure-time physical activity and lung cancer risk: A systematic review and meta-analysis.
Regular recreational physical activity may be associated with reduced risk of lung cancer.
»
11/05/15
Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.
SCIN may be a novel prognostic marker.
»
01/14/16
Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Downregulation of CTD903 enhanced Wnt/β-catenin activation.
»
01/30/16
Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
The patients having high HPV16 copy number in pretherapy and posttherapy cervical lesions showed increased disease recurrence with distant metastases.
»
04/07/16
The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
Interplay between HS and FGF-7 modulated downstream ERK, AKT and p38 cascades.
»
08/26/15
MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.
miR‑335 inhibited cell proliferation, migration and invasion in T24 and EJ cells.
»
05/04/15
ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals.
Targeting PCa S/P cells with ASC-J9(®) or inhibitors to interrupt the EZH2/STAT3 and/or Akt/EZH2/STAT3 signals may become a new therapy.
»
03/31/15
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
ER2 alone and in combination with cisplatin showed a significant anti-tumor efficacy in xenograft mouse models.
»
08/13/15
MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.
Down-regulation of miR-138 promoted the growth of cervical cancer cells.
»
04/07/16
Prognostic factors in male breast cancer: a population-based study.
ER positivity is associated with better prognosis.
»
03/19/16
< Prev
Next >